авторефераты диссертаций БЕСПЛАТНАЯ БИБЛИОТЕКА РОССИИ

КОНФЕРЕНЦИИ, КНИГИ, ПОСОБИЯ, НАУЧНЫЕ ИЗДАНИЯ

<< ГЛАВНАЯ
АГРОИНЖЕНЕРИЯ
АСТРОНОМИЯ
БЕЗОПАСНОСТЬ
БИОЛОГИЯ
ЗЕМЛЯ
ИНФОРМАТИКА
ИСКУССТВОВЕДЕНИЕ
ИСТОРИЯ
КУЛЬТУРОЛОГИЯ
МАШИНОСТРОЕНИЕ
МЕДИЦИНА
МЕТАЛЛУРГИЯ
МЕХАНИКА
ПЕДАГОГИКА
ПОЛИТИКА
ПРИБОРОСТРОЕНИЕ
ПРОДОВОЛЬСТВИЕ
ПСИХОЛОГИЯ
РАДИОТЕХНИКА
СЕЛЬСКОЕ ХОЗЯЙСТВО
СОЦИОЛОГИЯ
СТРОИТЕЛЬСТВО
ТЕХНИЧЕСКИЕ НАУКИ
ТРАНСПОРТ
ФАРМАЦЕВТИКА
ФИЗИКА
ФИЗИОЛОГИЯ
ФИЛОЛОГИЯ
ФИЛОСОФИЯ
ХИМИЯ
ЭКОНОМИКА
ЭЛЕКТРОТЕХНИКА
ЭНЕРГЕТИКА
ЮРИСПРУДЕНЦИЯ
ЯЗЫКОЗНАНИЕ
РАЗНОЕ
КОНТАКТЫ

Pages:     | 1 |   ...   | 8 | 9 ||

«Министерство здравоохранения Российской Федерации ГБОУ ВПО “УРАЛЬСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ” МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ...»

-- [ Страница 10 ] --

596. Шендеров, Б.А. Медицинская микробная экология и функциональное питание : пробиотики и функциональное питание : в 3 т. / Б.А. Шендеров. – М.:Грантъ, 2001. -Т.III. – 288 с.

597. Шендеров, Б.А. Нормальная микрофлора кишечника и некоторые вопросы микроэкологической токсикологии / Б.А. Шендеров // Антибиотики и медицинская биотехнология. – 1987.- №3. – С.164-170.

598. Шендеров, Б.А. Пробиотики и функциональное питание / Б.А. Шендеров, М.А. Маквелова, Ю.Б. Степанчук, И.Э. Скиба // Антибиотики и химиотерапия. – 1997. -№7. – С.30-34.

599. Шерлок, Ш. Заболевания печени и желчных путей : практ. руководство :

пер. с англ. / Под ред. З.Г. Апросиной, Н.А. Мухина / Ш. Шерлок, Дж.

Дули. –М.:ГЭОТАР-Медиа, 1999. – 864 с.

600. Шикмус, А.Ю. Применение пробиотиков при выращивании телят / А.Ю.

Шикмус // Сб. науч. трудов “Актуальные вопросы зоотехничекой науки и практики, как основа улучшенения продуктивности, качества и сельскохозяйственных животных”. – М.: Колос, 2001. – С.81-83.

601. Шифф, Ю.Р. Болезни печени по Шиффу. Цирроз печени и его осложнения.

Трансплантация печени : пер. с англ. / Под ред. В.Т. Ивашкина, С.В. Готье, Я.Г. Мойсюка. М.В. Маевской / Ю.Р Шифф, М.Ф. Соррел, У.С. Мэддрей. – М.:ГЭОТАР-Медиа, 2012. – 592 с.

602. Шмальгаузен, И.И. Пути и закономерности эволюционного процесса / И.И.

Шмальгаузен. М.:Изд-во “Либроком”, 2012. – 282 с.

603. Шмальгаузен, И.И. Факторы эволюции. Теория стабилизирующего отбора / И.И. Шмальгаузен. –М.:Наука, 1968. – 451 с.

604. Шувалова Е.П. Инфекционные болезни / Шувалова Е.П. – М.:Медицина, 1990. – 560 с.

605. Щекатихина, А.С. Гепатопротекторные свойства флаволигнанов / А.С.

Щекатихина // Труды Белорусского госуниверситета. –2009. –Т.4, №1. – С.27-48.

606. Щелгачев, В.В. Сравнительная характеристика пробиотиков на основе аэробных спорообразующих микроорганизмов / В.В. Щелгачев, П.Г.

Васильев, О.Е. Михайлов, А.Н. Васильев // Матер. юб. науч. конф.

“Диагностика, лечение и профилактика инфекционных заболеваний.

Биотехнология и ветеринария”. – Киров, 1998. – С.347-349.

607. Щелгачев, В.В. Технология приготовления препарата Биогель Б, предназначенного для лечения кожных поражений животных : автореф.

дис. …канд. биол. наук : 03.00.23 / Щелгачев Владимир Викторович. –М, 2006. – 18 с.




608. Щелгачев, В.В. Технология приготовления препарата Биогель Б, предназначенного для лечения кожных поражений животных : дис. …канд.

биол. наук : 03.00.23 / Щелгачев Владимир Викторович. –М, 2006. – 140 с.

609. Щербаков, П.Н. профилактика и лечение при желудочно-кишечных болезней телят / П.Н. Щербаков, А.Г. Гусев // Ветеринария. – 2002. -№3. – С.15.

610. Экспериментально-производственный регламент № 580 – 96. Биоспорин. – Екатеринбург, 1994. – Арх. Центра ВТП БЗ НИИМ. – Инв. №24.

611. Эпидемиологический анализ заболеваемости и другие методы эпидемиологической диагностики / С.Ф. Усик, А.Е. Билев, С.Н. Зинин и др.

–Самара:Офорт, 2007. – 158 с.

612. Эубиотики для профилактики, лечения и реабилитации больных при инфекционных заболеваниях и дисбактериозах : методические рекомендации / А.Т. Харечко, Л.П. Ларионов, Н.В. Литусов и др. – Екатеринбург, 1998. – 52 с.

613. Юшков, Б.Г. О влиянии ДМСО на кроветворение облученных и необлученных животных / Б.Г. Юшков, Н.А. Глотов, А.С. Барыбин, А.В.

Осипенко // Радиобиология. –Т.XX – Вып.1. -1980. -№1. – С.134-136.

614. Юшков, В.В. Иммунокорректоры : руководство для врачей и провизоров / В.В. Юшков, Т.А. Юшкова, А.В. Казьянин. – Екатеринбург: ООО “ИРА УТК”, 2002. – 255 с.

615. Юшков, В.В. Иммунокорректоры бактериального происхождения.

Эубиотики, вакциноподобные иммунокорректоры, липополисахариды / В.В. Юшков, Т.А. Юшкова, А.В. Казьянин // Иммунокорректоры :

руководство для врачей и провизоров. – Екатеринбург: ООО “ИРА УТК”, 2002. – С.149-176.

616. Юшков, В.В. Фармакология иммунокорректоров / В.В. Юшков, Т.А.

Юшкова, А.С. Ларионов. –Екатеринбург, 2005. – 164 с.

617. Ягода, А.В. Влияние противовирусной терапии на показатели фибринолиза при хронической вирусной патологии печени / А.В. Ягода, П.В. Корой // Медицинский вестник Северного Кавказа. –2010. - №1. – С.45-50.

618. Ягода, А.В. Патология печени и функция тромбоцитов (клинико патогенетический анализ) : монография / А.В. Ягода, П.В. Корой. – Ставрополь:СтГМА, 2008. – 274 с.

619. Язвенная болезнь, хронический гастрит и эзофагит в аспекте дисбактериоза эзофагогастродуоденальной зоны / В.В. Червин, В.М.

Червинец, В.М. Бондаренко, С.Н. Базлов. – Тверь:Изд-во ООО “Триада”, 2004. – 2000 с.

620. Яковлев, В.П. Современные фторхинолоны (ципрофлоксацин, левофлоксацин) в лечении инфекций кожи и мягких тканей / В.П. Яковлев // Антибиотики и химиотерапия. –2004. -Т.49, №8-9. – С.57-65.

621. Abramczuk, E. Effect of pathogenic factors on prognosis in patients with prosthetic valve endocarditis / E. Abramczuk, T. Hryniewiecki, J. Stepinska // Kardiol. Pol. –2007. –Vol.65, №2. – P.115-122.

622. Ackerman, S.J. Distinctive cationic proteins of the human eosinophil granule major basic protein, eosinophil cationic protein and eosinophil-derived neurotoxin / S.J. Ackerman, D.A. Loegering, P. Velge et al. // J. Immunol. 1983. –Vol.131, №6. – P.2977-2982.

623. Ahmad, N.M. Corynebacterium minutissimum pyelonephritis with associated bacteraemia : a case report and review of literature / N.M. Ahmad, K.M. Ahmad // J. Infect. –2005. –Vol.51, №5. – P.299-303.





624. Alternative therapies in antibiotic-resistant infection / B. Weber-Dabrowska, M.

Zimecki, M. Kruzel et al. // Adv. Med. Sci. –2006. –Vol.51. – P.242-244.

625. Antimicrobial action of carvacrol at different stages of dual-species biofilm development by Staphylococcus aureus and Salmonella enterica serovar Tiphimurium / J.R. Knowles, S. Roller, D.B. Murray, A.S. Naidu // Appl.

Environ. Microbiol. –2005. -Vol.71, №2. – P.797-803.

626. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003 / K.N. Schurek, H.J. Adam, C.G. Siemena et al. // J. Antimicrob. Chemother. – 2005. -Vol.56. – P.769-772.

627. Association between Fluoroquinolone Resistamce and Mortality in Escherichia coli and Klebsiella pneumoniae infections : the Role of Inadequate Empirical Antimicrobial / E. Lautenbach, J.P. Metlay, W.B. Bilker et al. // Clin. Infect. Dis.

–2005. -Vol.41. – P.923-929.

628. Ayala, A. Immune dysfunction in murine polymicrobial sepsis mediators, macrophages, lympocytes and apoptosis / A. Ayala, I.H. Chaudry / Shock, 1996.

-№6, Suppl.1. – P. 27-38.

629. Aвтор. свид-во СССР 1497211, МКИ4 С 12N 1/20, А 61 К 39/09. Штамм энтерококков Streptococcus faecium, используемый для приготовления бактерийных препаратов / В.М. Коршунов, Н.П. Иванова, Т.А. Логадырь, Б.А. Ефимов (СССР). №4360302/28-13.;

заявл. 08.01.88;

опубл. 30.07.89, Бюл. № 28.

630. Ball, P. Tolerability of fluoroquinolone antibiotics: past, present, future / P. Ball, G. Tilloston // Drag. Saf. –1995. -Vol.13. – P.313-358.

631. Bansal, S. Probiotics in health and diseasts / S. Bansal // J. Assoc physicians. – 2001. -№7. – P.735-741.

632. Bmer, G.W. Biotherapeutic Agents and Infection Diseases / G.W. Bmer, L.W.

Me Farland, C.M. Surawicz // Human Press. -1999. – P.316.

633. Bondarenko, V.M. Probiotics and mechanisms of their therapeutic effect [Электронный ресурс] / V.M. Bondarenko, R.P. Chuprynina, Z.I. Aladyscheva, T.V. Matzulevitz // Gamaleya Research Institute for Epidemiology and Microbiology, Tarasevich State Control Institute, Moscow. –М., 2006. –Режим доступа: http://www.rusmg.ru/php/content.php?id=6728. html.

634. Brandlzaeg, P. Two types of IgA immunocytes in man / P. Brandlzaeg // Nature New Biol 1973: 243: 126: – P.142-143.

635. Chuhrienko, N.D. Biosporin while allergic itching dermatosis treatment / N.D.

Chuhrienko, E.M. Dityatkovskaya, N.A. Agafonova // Allergy. –1992. –Vol.47, №12. – P.45.

636. Ciprandi, G. Effects of an adjunctive treatment with Bacillus subtilis for food allergy / G. Ciprandi // Chemiotherapia. -1986. -5, №6. – P.408-410.

637. Clausen, M.R. Lactulose, disaccharides and colonic flora / M.R. Clausen, P.B.

Mortensen // Clin. Consequense Drugs. –1997. -Vol.53. – P.930-942.

638. Clinical and Molecular Epidemiology of Extended-Spectrum Lactamase-Producing Escherichia coli as a Cause of Nosocomial infection or Colonization : Implications for Control / J. Rodryguez-Bano, M.D. Navarro, L.

Romero et al. // Clin. Infect. Dis. –2006. -Vol. 42. – P.37-45.

639. Comparison of clinical diagnosis and microbiological test results in vaginal infections / M. Karaca, A. Bayram, M.E. Kocoglu et al. // Clin. Exp. Obstet.

Gynecol. –2005. -Vol. 32, №3. – P.172-174.

640. Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring bacterium of the human skin flora / A. Tauch, O. Kaiser, T. Hain et al. // J.

Bacteriol. –2005. -Vol.187, №13. – P.4671-4682.

641. Cummins C.S. Bacterial cell wall structura / C.S. Cummins // CRC Handbook of microbiology : Microbial composition : carbohydrathes, lipids and mincrals. – Boca Raton, CRC Press, 1982. – Vol. 4. – P.197-327.

642. Davies, J.E. Origins, acquisition and dissemination of antibiotic resistance determinants, In : Chardwick D.J. editor. Antibiotic resistance: origins, evolution, selection and spread / J.E. Davies // Chinester (UK) : John Wiley and Sons Ltd. –1997. – P.15-35.

643. Decheshe, J.P. Influense de quelques plastificants les proprieties de resistance mecanique de films insoles oil acetylphtalate de cellulose (CAP) / J.P. Decheshe, T.R. Jaminef // J.Pharm.-Belguque. -1985. -V.40, №1. – P.13-18.

644. Dissemination and diversity of metallo-B-lactamases in Latin America : report from the SENTRY Antimicrobial Surveillance Program / H.S. Sader, M.

Castanheira, R.E. Mendes et al. // J. Antimicrob. Agents. –2005. -Vol.25, №1. – P.57-61.

645. Dittgen, M. Untersuchungen der Bioadnesion von poliacrylaten / M. Dittgen // Pharmazie. –1988 –Bd.43, №.2. – S.870-871.

646. Dittgen, M. Untersuchungen von Arzneistoff und Tragezeinflussen auf die Arzneistoff diffusion aus Acrilatfilmen / M. Dittgen, W. Sttahlkopf // Pharmazie.

–1984. – Bd. 39, №.12. – S.625-627.

647. Doelker, E. Proposition de classification des polymers biocompatible pour les formes medicamentanses a liberation controles / E. Doelker // Sci. Techn. Pract.

Pharm. –1987. –Vol.3, №3. – P.207-215.

648. Dubois, R.S. Chronic active hepatitis and pregnancy : a report of two cases in adolescence / R.S. Dubois, Th. Slovis // Gastroenterology. –1982. -Vol.77. – P.649-651.

649. Effect of certain bioactive plant extracts on clinical isolates of beta lactamase producing methicillin resistant Staphylococcus aureus / F. Aqil, M.S.

Khan, M. Owais, I. Ahmad // J. Basic. Microbiol. –2005. - Vol. 45, № 2. – P.106-114.

650. Effect of perorally administered Lactobacilli on macrophage activation in mice / G. Perdigon, M.E.N. Macias, S. Alvarez et al. // Infect. Immun. –1986. -Vol.53, №2. – P.404-410.

651. Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms / A. Nostro, A.S. Roccaro, G. Bisignano et al. // J. Med. Microbiol. –2007. -Vol.56, Pt.4. – P. 519-523.

652. Emmerzon, A.M. The second national prevalence survey of infection in hospitals : methodology / A.M. Emmerzon, J.E. Enstone, M.C. Kelsey // J.

Hosp. Infect. –1995. -№30. – P.7-29.

653. Etude de films a base hydroxypropylmethylcellulose phtalate (HP 55) / J.

Salloum, J.P. Laget, M.L. Galen, J. Passet, H. Delonca //J.Pharm. Belg. –1989. – Vol.44, №2. – P.101-108.

654. Evaluation of API Coryne System, version 2.0, for diphteroid gram-positive rods identification with clinical relevance / M.N. Almuzara, C. DeMier, C.R.

Rodriguez, A.M. Famiglietti, C.A. Vay // Rev. Argent. Microbiol. –2006. Vol.38, №4. – P.197-201.

655. Experimental study on the efficacy of combinations of glycopeptides and lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides / A. Domenech, S. Ribes, C. Cabellos et al. // J. Antimicrob.

Chemother. –2005. -Vol.56. – P.709-716.

656. Fadden, K. Alteration in fecal microflora enzymes related to diet, age, Lactobacillus supplements and dimethylhydrazine / K. Fadden, M.J. Hill, R.W.

Owen, B.R. Goldin, S.L. Gorbach // Cancer. -1998, №40. – P.2421-2426.

657. Farkas-Himsley, H. Sensitivity it bactericin of murine leukemia`s with varying oncogenic potency / H. Farkas-Himsley // Microbios.Lett. -1980, №15. – P.89 96.

658. Fernandes, C.F. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products / C.F. Fernandes, K.M. Shahani, M.A. Amer // FEMC Microbiol.Rev. -1987. –Vol.466. – P.343-356.

659. Flemming, M. A rheological assessment of the nature of interactions between mucoadhesive polymers and homogenized mucus hel. / M. Flemming, E.

Kirsten, J. Smart // D. Biomaterials. – 1988. – Bd.19, №11-12. – P.1083-1092.

660. Floch, M.H., Hong-Curtiss J. Probiotics and functional foods in gastrointestinal disorders / M.H. Floch, J. Hong-Curtiss // Curr.Gastroenterol Rep 2001:3:343 50.

661. Folwaczny, C. Probiotics for prevention of ulcerative colitis recurrence:

alternative medicine added to standard treatment / C. Folwaczny // J.

Gastroenterol. 2000:38:547-50.

662. Fraise, A.P. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? / A.P. Fraise // J. Infect. –2006. -Vol. 53, №5. – P.293-300.

663. Freer, J.H. Toxins of Staphylococcus aureus / J.H. Freer, J.P. Arbuthnott // Pharmacol. Ther., 1983. -Vol.19. – P. 55-106.

664. Freter, R. Factors affecting – the colonization of the gut by Lactobacilli and other bacteria / R. Freter, M.E. De Macias // In: Old Herborn University Seminar Monograph. Probiotics of use in Opportunistic Infections, 1995. -№8. – P.256 420.

665. Fuller, R. Probiotics in human medicine / R. Fullar // Gut. –1991. –32, №4. – P.439-442.

666. Fuller, R. Probiotics: prospects of use in opportunistic infections / R. Fuller. N.Y., 1995.

667. Gander, S. Telavancin : in vitro activity against staphylococci in Telavancin :

in vitro activity against staphylococci in a biofilm model / S. Gander, A.

Kinnaird, R. Finch // J. Antimicrob. Chemother. –2005. -Vol.56. – P.337-343.

668. Gandi, R.B. Bioadhesion in drug delivery / R.B. Gandi, J.R. Robinson // Jnd. J.

Pharm. Sci.-1988. –V.43, №.12. – P.145-152.

669. Ganz, T. Defensives and other endogenous peptide antibiotics of vertebrates / T.

Ganz, E. Martin, R.I. Lehrer // AI. Leu k. Biol. -1995. – P.128-136.

670. Gelfand, J.A. Infections in burn patients: A paradigm for cutaneous infections in the patient at risk //Am. J. Med., 1984. -Vol. 76. – P.158-165.

671. Genetics and Biotechnology of Lactic Acid Bacteria / (eds. M.J. Gasson and W.M. de Vos) // Blackie Academic and Professional, Glasgow. -1996. –P.211 251.

672. Gibson, G.R. Dietary modulation of the human colonic micro-biota: introducing the concept of prebiotics / G.R. Gibson, M.B. Roberfroid // J Nutr 1995: 125:

1401-12.

673. Gilliland, S.E. Antagonistic action of Lactobacillus acidophilus toward intestinal and food-bome pathogens in associative culture / S.E. Gilliland // FEMS Microbiol.Rev. -1990. -Vol.87. – P. 138-142.

674. Global probiotics market is expected to be worth $32.6 billion by [Электронный ресурс] // News-Medical.Net, 2010. – Режим доступа:

http://www.news-medical.net/news/20100113/Global-probiotics-market-is expected-to-be-worth-24326-billion-by-2014.aspx.html.

675. Goossens, H. Outpatient antibiotic use in Europe and association with resistance : a cross-national database study / H. Goossens, M. Ferech, R.V. Stichele // Lancet. –2005. -Vol.365. – P.579-582.

676. Gopal, P. In vitro adherence properties of L. rhamnosus DR20 and B. lactis DR10 strains and thtir antagonistic activity against an enterotoxigenic E. coli / P.

Gopal // Int J. Food Microbiol. – 2001. -№5. – P.207-216.

677. Gordon, J.I. Interactions between epithelial cells and bacteria / J.I. Gordon, L.V.

Hooper, I. Bry, T. Midtvedt, P.G. Falk // Science. -1997. –№276. –P.965.

678. Guida, V. Importansia dos Bacillos esporulados aerobios em gastroenterology e nutricao / V. Guida, R. Guida // Rev. Brasil. Med. – 1978. -Vol.35, №12. – P.702-707.

679. Guo, Jan-Hwa. The of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches / Jan-Hwa Guo, K.M. Coocklock // J. Pharm. Pharmacol. –1996. –Vol. 48, №3. – P.255-258.

680. Gustafson, E.J. Interaction of PMNs (Polymorphonuclear cells with contact activation factors) / E.J. Gustafson, R.W. Colman // Seminars Thromb. HemoS. 1987. –Vol.13. – P.95-104.

681. Havenaar, R. Huis in`t Veld JHJ. Selection of strains for probiotic use / R.

Havenaar, B. Ten Brink // Probiotics. The scientific basis. –London: Chapman & Hall, 1992. – P.209-224.

682. Hisanaga, T. Mechanisms of resistance to telithromycin in Mechanisms of resistance to telithromycin in Streptococcus pneumoniae / T. Hisanaga, D.J.

Hoban, G.G. Zhanel // J. Antimicrob. Chemother. –2005. -Vol.56. – P.447-450.

683. Hoerr, R.A. Bioactive proteins and probiotic bacteria: modulators of nutritional health / R.A. Hoerr, E.F. Bostwick // Nutrition. -Vol.16, №7/8, 2000. – P.711 713.

684. Holzapfel, W.H. Introduction to pre- and probiotics / W.H. Holzapfel, U.

Schillinger // Food Research International 35 (2002). – P.109-116.

685. Huis, in`t Veld JHJ. Selection criteria for probiotic microorganisms / Huis in`t Veld JHJ, C. Shortt // Gut flora and health – past, present and future. –London, New York: Royal Society of Medicine Press Limited, 1996. – P.27-36.

686. Hunter, J.O. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics / J.O. Hunter, J.A. Madden // Br. J.

Nutr.2002;

88, suppl. D. – P.67-72.

687. In vitro activities of non-traditional antimicrobials alone or in combination against multidrag-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units / F. Timurkaynak, F.

Can, O.K. Azap et al. // Int. J. Antimicrob. Agents. –2006. -Vol.27, №3. – P.224-228.

688. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levoflocsacin and ciprofloxacin alone and in combination with B-lactams and amicacin / L. Drago, E. De Vecchi, L. Nicola et al. // J.

Antimicrob. Chemother. –2005. -Vol.56. – P.353-359.

689. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings / C. Dunne, L. O`Mahony, L. Murphy et al. // Am J. Clin. Nutr., 2001;

73(suppl):386S-92S.

690. Irvine, R.F. How is the level of free arachidonic acid controlled in mammalian cells / R. F. Irvine // Biochem. J. -1982. –№204. – P.3-16.

691. Ishibashi, N. Probiotics and safety / N. Ishibashi, S. Ymazaki // Am..J. Clin.

Nutr. 2001;

73 (suppl): 465-470.

692. Isolauri, E. Probiotics in human disease / E. Isolauri // Am J. Clin. Nutr., 2001;

73(suppl). – P.1142-1146.

693. Janick, S. Untersuchung der in vitro – freigabegeschwindigkeit von Isosorbiddinitrat aus einem transdermalen terapeutischen Membransystem / S.

Janick, H. Gabiga // Pharmazie. -1989. – Bd.44, №1. – S.68.

694. Joint FAO/WHO group : guidelines for the evaluation of probiotics in food. – 2002. – P.1-11.

695. Kailasapathy, K.A. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. / K.A.

Kailasapathy, J. Chin // Immunol. Cell. Biol. –2000. -Vol.78. – P.80-88.

696. Kamysz, W. Are antimicrobial peptides an alternative for conventional antibiotics? / W. Kamysz // Nucl. Med. Rev. Cent. East Eur. –2005. -Vol.8, №1.

– P.78-86.

697. Kassem, M.A. In vitro release of dexametazone from different polimeric inserts / M.A. Kassem, M.A. Abbia, S.M. Safwat // J. Pharm.-Belgique. -1985. –Vol.40, №1. – P.5-13.

698. Kauffman, C.A. Candiduria / C.A. Kauffinan // Clin. Infect. Dis. –2005. -Suppl.

41. – P.371-376.

699. Kelley, J.L. Activation of human blood monocyte by adherence totissue culture plastic syrfaces / J.L. Kelley, M.M. Rozek, C.F. Suenram // Exp. And Mol.

Pathol. -1987. -Vol.46. - №3. – P.266 -278.

700. Knoch, A. Theorie und Pracxiz transdermaller freigabesysteme / A. Knoch, H.P.

Merkle //Acta Pharm. technol.-1985.-Vol. 31, №4. – P.197-209.

701. Lack of extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection / М.

Palma, S. Nozohoor, T. Schennings et al. // -Infect. Immunity, 1996. -Vol.64, №12. – P.5284-5289.

702. Lactic acid bacteria / S. Salminen, A., von Wright A., A.C. Ouwehand // microbiological and Functional Aspects (3rd ed.). – New York:Marcel Dekker, Inc., 2004. – P.375-395.

703. Larionov, L.P. The elaboration of new elementorganic hydrogels for pharmaceutical compositions of local and external application / L.P. Larionov, T.G. Khonina, P.V. Sorokin et al. // Material of International conference Рharmacology. –Harbin. China, 2008. – P.4-5.

704. Lee, Y.K. Handbook of Probiotics and Prebiotics / Y.K. Lee, S. Salminen. – 2rd rev. ed. –John Wiley and Sons, Ltd., 2009. – 161 p.

705. Linares-Rodriguez, J.F. Antimicrobial resistance and bacterial virulence / J.F.

Linares-Rodriguez, J.L. Martinez-Menendez // Enferm. Infecc. Microbiol. Clin.

–2005. -Vol.23, №2. – P.86-93.

706. Lippold, B.C. Choel of lipofilic polimer material for transdermal therapeutic system and control of release Phactical considerations / B.C. Lippold // Pharm Industr. – 1988. -Vol.49, №12. – P.1295-1300.

707. Lyons, T.P. The probiotic concept: comming of age / T.P. Lyons, R.J. Fallon // World Biotech. Rept., 1986. prot. Conf., San Francisco, nov. 1986. -Vol.2., Pt.7., New York, London. 1986. – P.69-80.

708. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis / S.J. Phaff, W.M. Tiddens, H.A.

Verbrugh, A. Ott // J. Antimicrob. Chemother. –2006. -Vol.57. – P.741-746.

709. Marteau, P. Impact of ingested lactic acid bacteria on the immune response in man / P. Marteau // Lactic acid bacteria, actes du colloque Lactic 94. - Caen:

Presses Universitaires de Caen, 1995. – P.31-42.

710. Marteau, P. Nutritional advantages of probiotics and prebiotics / P. Marteau, M.C. Boutron-Ruault // British Journal of Nutrition, 2002. –Vol.87, Suppl.2. – P.153-157.

711. Martinez, F.D. Role of microbial burden in aetiology of allergy and asthma / F.D. Martinez, P.G. Holt // Lancet. –1999;

354 (suppl 2):12-15.

712. Mazuda, N. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa / N. Mazuda, E. Sacagawa, S. Ohya // Atimicrob.

Agents Chemother. –1995. -Vol.39. – P.645-649.

713. Mc Farland, L.V. Biotherapeutic agents: boon or bane? / L.V. Mc Farland // Microbil. Ecol. Health and Disease. -1994.-7, №1. – P.585-586.

714. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms / J.A.T. Sandoe, J. Wysome, A.P. West et al. // J.

Antimicrob. Chemother. –2006. -Vol.57. – P.767-770.

715. Messens, W. Inhibitory substances produced by Lactobacilli isolated from sourdoughs - a review / W. Messens, L.D. Vuyst // Intern. J. Food Microbiol. – 2002. -Vol.72, №1-2. – P.31-43.

716. Mode of action, purification and amino acid sequence of plantaricin С19, anti Listeria bacteriocin produced by Lactobacillus plantarum C19 / A. Atrin, N.

Rekhif, A.J. Moir et al. // Intern. J. Food Microbiol. – 2001. -Vol.68. – P.93-104.

717. Muratani, T. Bacterial resistance to antimicrobials in urinary isolates / T.

Muratani, T. Matsumoto // Intern. J. Antimicrob. agents. –2004. -Vol.24. – P.

28-31.

718. Najda, J. The effect of silicon (Si) on lipid parameters in blood serum and arterial wall / J. Najda, J. Gminski, M. Drozdz, A. Flak // Biol. Trace Elem. Res.

-1991 De, 31 (3). – P.235-247.

719. Nanicki, S. Otzzynywanie dyfuzyijnego systemu terapeuty c znego z siarczanem litowym / S. Nanicki, Z. Jedras, M. Flozezak // Farm. Pol.-1988. – Bd. 44, №4. – S.331-333.

720. Neopeptide antibiotics thet function as opsonins and membrane permeabilizing agents for gram-negative bacteria / H. Tsubery, H. Yaakov, S.

Cohen et al. // Atimicrob. Agents Chemother. –2005. -Vol.49. – P.3122-3128.

721. New perspectives for a new century : implications of pathogen responses for the future of antimicrobial therapy / K.A.J. Melstrom, J.W. Smith, R.L. Gamelli, R. Shankar // J. Burn. Care. Res. –2006. -Vol.27, №3. – P.251 264.

722. Nordmann, P. Emergence of plasmid-mediated resistance to quinolones Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae / P. Nordmann, L. Poire // J. Antimicrob. Chemother. –2005. -Vol. 56. – P.463 469.

723. Ogawa, M. Inhibition of in vitro growth of Shiga toxin-producing E. coli О 157:H7 by probiotic Lactobacillus strains due to production of lactic acid / M.

Ogawa, K. Shimizu, K. Nomoto, R. Tanaca // Int J. Food Microbiol. –2001. №2. – P.135-140.

724. Ononokpono, O.E. The effects of inclusions and conditions of storage on the mechanical properties of maize starch and methylcellulose films / O.E.

Ononokpono, M.S. Spring // J. Pharm. Pharmacol. -1988. –Vol.40, №5. – P.

313-319.

725. Orhage, K. Bifidobacteria and lactobacilli in human health / K. Orhage, C.E.

Nord // Drugs Exp. and Clin. Res. –2000. -Vol.26, №3. – P.95-111.

726. Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA / L.

Poirel, J.-M. Rodriguez-Martinez, H. Mammeri et al. // Antimicrob. Agents Chemother. –2005. -Vol.49, №8. – P.3523-3525.

727. Park, B.H. Infection and nitrobluetetrazolium reduction by neutrophils / B.H.

Park, S.M. Fikrig, E.M. Smithwick // Lancet. -1968. -№2. – P.532-534.

728. Parker, R.B. Probiotics, the other half of the antibiotic story / R.B. Parker // Anim. Nutr. Health. 1974, 29:4-8.

729. Pendurkar, S.H. Heat resistance of Bacillus spores exposed to food processing conditions / S.H. Pendurkar, P.R. Kukarni // Nahrung. –1990. -34, №2. – P. 177 180.

730. Perdigon, G. Lactic acid bacteria and their effect jn the immune system / G.

Perdigon, R. Fuller, R. Raya // Curr. Issues intes Microbiol. – 2001. – P.27-43.

731. Perdigon, G. Lactobacilli administered orally induce release of enzymes from peritoneal macrophages in mice / G. Perdigon, S. Alvarez, M.E. Nader de Macias // Milchwiss. –1986. -Vol.41, №6. – P.344-348.

732. Pflegel, P. Arzneimittel und Organismus (IV). Transdermale therapeutische systeme / P. Pflegel, M. Dittgen //Pharmazie. –1987. –Bd. 42, -№12. – S. 799 809.

733. Piddock, L.J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria / L.J. Piddock // Clin. Microbiol. Rev. –2006. -Vol.19, №2. – P.382-402.

734. Piddock, L.J. Multidrug-resistance efflux pumps – not just for resistance / L.J.

Piddock // Nat. Rev. Microbiol. –2006. -Vol. 4, №8. –P. 629-636.

735. Plotrowski M.C. Pseudomonas aeruginosa strains posses specific adhesins for laminin / J.H. Tournier, E. Puchelle // -Infect. Immunity, 1996. -Vol.64. -№2. – P.600-605.

736. Population structure of Enterococcus faecium causing bacteriemia in a Spanish University Hospital : setting the scene for a future increase in vancomycin resistance? / T.M. Cuque, R.J.L. Willems, J. Fortun et al. // Atimicrob. Agents Chemotherapy. –2005. -Vol. 49. – P.2693-2700.

737. Pre- and Probiotics 2013: Yes, let’s call it unmissable [Электронный ресурс] // Режим доступа:

Events.wavecastpro.com, 2013. – http://events.wavecastpro.com/preandprobiotics2013?utm_source=NewsNIArtic leID&utm_medium=EditoArcticle&utm_campaign=AttPPB13.html.

738. Predicting antimicrobial resistance invasive pneumococcal infections / O.G.

Vanderkooi, D.E. Low, K. Green et al. // Clinical Infectious Diseases. –2005. Vol.40, №9. – P.1288-1297.

739. Preisig, R. Supplements to the editorial “Liver protection therapy” / R. Preisig // Schweiz. Rundsch. Med. Prax. –1970. -Vol.59. – P.1559-1560.

740. Probiotic penetration: Yakult takes a shot at Southern India [Электронный ресурс] Режим доступа:

// Foodnavigator.com, 2012. – http://www.foodnavigator.com/content/search?SearchText=India+probiotics+ma rket.html.

741. Probiotics in primary prevention of atopic disease: a randomised placebo controlled trial / M. Kalliomki, S. Salminen, H. Arvilommi et al. // Lancet. – 2001. – P.1076-1079.

742. Probiotics in the management of atopic eczema / E. Isolauri, T. Arvola, Y. Stas et al. // Clin. Exp. Allergy 2000. – P.1605-1610.

743. Probiotics: effects on immunity / E. Isolauri, Y. Sutas, P. Kankaanpaa et al. // J.

Clin. Nut.2001;

73(suppl. 2). – P.4448-4450.

744. Pseudomonas aeruginosa exotoxin A: it`s role in retardation of wound healing / J.P. Heggers, S. Yaydon, F. Ко, P.G. Hayward et al. //-J.Burn Care Rehab., 1992. -Vol.13. – P.512-518.

745. Rajech, D. Bioadhesion in drug delivery / D.Rajech, Gandi and Joseph R.

Robinson //Indian Pharm. Sci. –1988. -Vol. 50, №3. – P.145-152.

746. Rappaport, A.M. Subdivision of hexagonal liver lobules into a structural and functional unit / A.M. Rappoport, Z.J. Borowy, W.M. Lougheed, N. Lotto // Anat Rec. –1954. - Vol.119. – P.11-34.

747. Reid, G. Probiotics for urogenital healf / G. Reid // Nutr. Clin Care. – 2002. – P.3-8.

748. Reinert, R. Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003 / R. Reinert, S. Reinert // Antimicrob.

Agents Chemother. –2005. -Vol.49, №7. – P.2903-2913.

749. Rex, J.H. Resistans of Candida albicans species to fluconazole / J.H. Rex, M.G.

Rinald, M.A. Pfaller // Atimicrob. Agents Chemother. –1995. -Vol.39. –P.1-8.

750. Risk Factors for increasing Multidrag Resistance among extendent-spectrum lactamase producing Escherichia coli and Klebsiella species / E.P. Hyle, A.D.

Lipworth, T.E. Zaoutis et al. // Clinical Infectious Diseases. –2005. -Vol.40, №9.

– P.1317-1324.

751. Ritschel, W.A. Use of sorption promoters to increase systemic absorption of comate from transdermal drug delivery systems / W.A. Ritschel, J.K. Barkhaus // Arzneimittel Forsch. –1988. –Vol. 38, №12. – P.1774-1777.

752. Roberfroid, M.B. Prebiotics and probiotics: are they functional foods? / M.B.

Roberfroid // Am. J. Clin. Nutr. –2000. 71:Suppl:6. – P.1682-1687.

753. Robson, M.C., Kucan J.O. The burn wound, in Wachtel T. L., Kahn V., Frank H.A. (eds). - Current Topics in Burn Care / M.C. Robson, J.O. Kucan // Rockville Md., Aspen Systems Corp.,1983. – P. 55-63.

754. Rocchietta, J. The use of Bacillus subtilis in the treatment of the diseases / J.

Rocchietta // Minerva Med. – 1969. –V.60, №3/4. – P.117-123.

755. Roffe, C. Biotherapy for antibiotic-associated and other diarrhoeas / C. Roffe // J. Infect. -1996. –№32. – P.1-10.

756. Role of manganese superoide dismutase in a mucoid isolate of Pseudomonas aeruginosa adaption to oxidative stress / В. Polack, D. Dacheux, I. Delic-Atree et al. // Infect, immunity, 1996. -Vol. 64. – P.86-89.

757. Rolfe, R.D. The role of probiotic cultures in the control of gastrointestinal health / R.D. Rolfe // J. Nutr. – 2000. –Vol.130, №2 (suppl.). – P.396-402.

758. Rollany, H. Effect of beta-interferon on in vitro of mouse peritoneal macrophages / H. Rollany, H. Degre //Acta Pathol. Microbiol.-Immunol. Scand.

-1982. - Vol.890. - №6. – P.389-395.

759. Rolston, K.V.I. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer / K.V.I.

Rolston // Clinical Infectious Diseases. –2005. -Vol.40, №4. – P.246-252.

760. Roos, N.M. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998 / N.M.

Roos, M.B. Katan // Am J. Clin. Nutr., 2000;

71:405-11.

761. Rowland, I.R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora / I.R. Rowland, R.

Tanaka // J. Appl. Bacteriol. –1993. -Vol.74. – P.667-674.

762. Ruchim, M.A. Volatile Fatty Acids degradation By Human Fecal Suspensions / M.A. Ruchim, D. Makino // Gastroenterol. -1984. – Vol.86. – P.236.

763. Russel, J. Ожог / J. Russel. – U.K., Edinburgh: LENNEX Corp., 2012. – P.4-9.

764. Russel, J. Пробиотики / J. Russel, R. Cohn. – U.K., Edinburgh: LENNEX Corp., 2012. – P.5-58.

765. Ruter, A. Phagocyte-pathogenic microbe interactions / C.H. Chastellier // Int.

Rev. Cytol. – 1983. -Vol.85. – P.287-327.

766. Sader, H.S. Antimicrobial susceptibility of uncommonly isolated non-enteric gram-negative Bacilli. Review / H.S. Sader, R.N. Jones // J. Antimicrob. Agents.

–2005. -Vol.25, №2. – P.95-109.

767. Salminen, S. Lactulose, lactic acidbacteria, intestinal microecology and mucosalprotection / S. Salminen, E. Salminen // Scand J. Gastroenterol. 997: (suppl). – P.45-48.

768. Schnaper, H.W. A role for histamine type (H-2) receptor binding in production of the lymphokine, solubke immune response suppressor / H.W. Schnaper, T.M.

Aune, R.K. Roby // J. Immunol. -1987. –Vol.139. – P.1185-1190.

769. Seglen, P.O. Preparation of isolated rat liver cells / P.O. Seglen // Methods in Cell Biology. Academic Press. – 1976. –Vol.13. – P.29-83.

770. Shanahan, F. Probiotics in inflammatory boweldisease / F. Shanahan // Gut 2001:48:609.

771. Sheldon, A.T.J. Antibiotic resistance: a survival strategy / A.T.J.

Sheldon // Clin. Lab. Sci. –2005. -Vol.18, №3. –P.170-180.

772. Simon, L.L. Intestional microflora / L.L. Simon, S.L. Lorbach // Med. Clin.

North. Amer. -1982. –Vol.66. – P.557-574.

773. Snygerman, R. Structure and Function of monocytes and macrophages / R.

Snygerman, M.C. Pike // Arthritis andallied conditions / Ed. D. McCarty. – N.Y.:Lea a. Febiger, 1989. – P.306-335.

774. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis unit / A.M. Jones, J.W.R. Govan, C.J. Doherty et al. // Lancet. –2001. Vol.358. – P.557-558.

775. Spread of efflux pump-overexpressing, non-metallo--lactamaseproducing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity / S. Pournaras, M. Maniati, N.Spanakis et al. // J. Antimicrob. Chemother. –2005. -Vol.56. – P.761-764.

776. Starling, S. DuPont’s Danisco buy boosts probiotics and could spur further acquisitions [Электронный ресурс] / S. Starling // Foodnavigator.com, 2011. – Режим доступа: http://www.foodnavigator.com/Financial-Industry/DuPont-s Danisco-buy-boosts-probiotics-and-could-spur-further-acquisitions.html.

777. Studies of the dioavailability of nitroglycerin from a transdermal therapeutiuc system (Nitroderm TTS) / Europ. L. Din Pharmacology. –1984. –Vol. 27, №.1. – P.7-9.

778. Surawicz, C.M. Prevention of anribiotic associated diarrhea by Saccharomyces boulardii: a prospective study / C.M. Surawicz, G.W. Elmer, P. Speelman // Gastroenterology. -1989;

096: – P.981-988.

779. Swarz, M.N. Use of antimicrobial agents and drug resistance / M.N. Swarz // N.

Engl. J. Med. –1977. -Vol.337. – P.491-492.

780. Sweet`s syndrome associated with skin methicillin-resistant Staphylococcus epidermidis infection / T. Xiao, C.D. He, X.H. Gao, H.D. Chen // J. Dermatol. –2007. -Vol.34, №4. – P.258-261.

781. Symposium: probiotic baceria for humans: clinical systems for evaluation of effectiveness. Immune system stimulation by probiotics / G. Perdigon, S.

Alvarez, M. Rachid et al. // J. Dairy Sci. –1995. -Vol.78, №12. – P.1597-1606.

782. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus / L.C. Braga, A.A. Leite, K.G. Xavier et al. // Can. J. Microbiol. –2005. -Vol.51, №7. – P.541-547.

783. Synthesis and biological activity of organosilicontitanium glycerohydrogels / T.G. Khonina, O.N. Chupakhin, A.L. Suvorov et al. // Pharmaceutical Chemistry Journal. New York: Springer New York Consultants Bureau, 2009. –V43, №2. – P.95-100.

784. Tannock, G. M. The Normal Microflora New Conctpts in Health Promotion / G.

M. Tannock // Microbiologinal Scinees. – 1988. – Vol.5. – P.176.

785. Tannock, G.W. Genetic manipulation of gut microorganisms / G.W. Tannock // Probiotics. The scientific basis. – London: Chapman & Hall, 1992. – P.181-207.

786. Tannock, G.W. Probiotics // A Critical Review Horizon Sci Press, Norfolk, England. 1999.

787. Thach, P.N. Le Bacillus subtilis en therapeutique et dans la prophilaxie / P.N.

Thach, T.C. Vu, T.H. Nguen // Rev. Immuol. -1968. -72, №1. – P.53-58.

788. The United States Pharmacopeia. The National Formulary (Pharmaceutical Dosage Form). –USP –23. -NF18. –1995. – P.1949-1799.

789. Toon, S. Rate and extent of absorption of clonidine from a transdermal therapeutic system / S. Toon, K.J. Hopkins, L. Aarons, M. Rowland // Pharm.

Pharmacol. –1989. –Vol.41, №1. – P.17–21.

790. Up-to-date clinical and experimental basis for the use of probiotics / F.J. Penna, L.A.P. Filho, A.C. Calcado et al. // Jornal de Pediatria, 2000. -Vol.76, Supl.2. – P.209-217.

791. Vanbelle, M. Probiotics in animal nutrition : a review / M. Vanbelle, E. Teller, M. Focant // Arch. Tierernahr. 1990. -Vol.40, №7. – P.543-567.

792. Vidal 2013 : справочник Видаль. Лекарственные препараты в России. – М.:ЮБМ Медика Рус, 2013. – 1640 с.

793. Virulence factors of Pseudomonas aeruginosa / G. Doring, M. Maier, E. Muller, Z. Bili et al. // Antibiot. Chemother., 1987. -Vol.39. – P.136-148.

794. Walker, R. Probiotic microbes: the scientific basis [Электронный ресурс] / R.

Walker, M. Buckley // A report from the American Academy of Microbiology, 2006. – Режим доступа: http://www.antibiotic.ru/index.php?article=1386.html.

795. Wannamaker L. Streptococcal toxins / L. Wannamaker // Rev. Infect. Dis., 1985.

-№5 (Suppl. 4). – P.723-732.

796. Wareham, D.W. In-vitro activity of polymyxin В in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases / D.W. Wareham, D.C. Bean // Ann. Clin. Microbiol. Antimicrob. –2006. -Vol.21, №5. – P.10.

797. Wingard, J.R. Increase in Candida krasei infection among patients with bone marrow transplantation and neutropenia treatment prophylactically with fluconazole / J.R. Wingard // N. Engl. J. Med. –1991. -Vol.325. – P. 1274-1277.

798. Young woman with granulomatous mastitis : a corynebacteria may be involved in the pathogenesis of these disease / P. Kieffer, R. Dukic, M. Hueber et al. // Rev. Med. Interne. –2006. -Vol.27, №7. – P.550-554.

799. Ziegenmeyer, J. TTS: Transdermale Application von Arzneistoffen / J.

Ziegenmeyer // Pharm. Ztg. –Bd.134, №2. – S.24–30.

800. Zitting, A. Biological Activity of Titanium Dioxides / A. Zitting, E. Skytta // Int. Arch. Occup. Environ. Health, 1979. -43, 2. – P.93-97.



Pages:     | 1 |   ...   | 8 | 9 ||
 





<

 
© 2013 www.libed.ru - «Бесплатная библиотека научно-практических конференций»

Материалы этого сайта размещены для ознакомления, все права принадлежат их авторам.
Если Вы не согласны с тем, что Ваш материал размещён на этом сайте, пожалуйста, напишите нам, мы в течении 1-2 рабочих дней удалим его.